Literature DB >> 30705128

Ventricular mass as a prognostic imaging biomarker in incident pulmonary arterial hypertension.

Catherine E Simpson1,2, Rachel L Damico1,2, Todd M Kolb1, Stephen C Mathai1, Rubina M Khair1, Takahiro Sato3, Khalil Bourji4, Ryan J Tedford5, Stefan L Zimmerman6, Paul M Hassoun1.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 30705128      PMCID： PMC7263169          DOI： 10.1183/13993003.02067-2018

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  14 in total

1.  Prognostic value of right ventricular mass, volume, and function in idiopathic pulmonary arterial hypertension.

Authors:  Serge A van Wolferen; Johannes T Marcus; Anco Boonstra; Koen M J Marques; Jean G F Bronzwaer; Marieke D Spreeuwenberg; Pieter E Postmus; Anton Vonk-Noordegraaf
Journal:  Eur Heart J       Date:  2007-01-22       Impact factor: 29.983

Review 2.  Right ventricular function in cardiovascular disease, part II: pathophysiology, clinical importance, and management of right ventricular failure.

Authors:  François Haddad; Ramona Doyle; Daniel J Murphy; Sharon A Hunt
Journal:  Circulation       Date:  2008-04-01       Impact factor: 29.690

Review 3.  Right heart adaptation to pulmonary arterial hypertension: physiology and pathobiology.

Authors:  Anton Vonk-Noordegraaf; François Haddad; Kelly M Chin; Paul R Forfia; Steven M Kawut; Joost Lumens; Robert Naeije; John Newman; Ronald J Oudiz; Steve Provencher; Adam Torbicki; Norbert F Voelkel; Paul M Hassoun
Journal:  J Am Coll Cardiol       Date:  2013-12-24       Impact factor: 24.094

4.  Progressive right ventricular dysfunction in patients with pulmonary arterial hypertension responding to therapy.

Authors:  Mariëlle C van de Veerdonk; Taco Kind; J Tim Marcus; Gert-Jan Mauritz; Martijn W Heymans; Harm-Jan Bogaard; Anco Boonstra; Koen M J Marques; Nico Westerhof; Anton Vonk-Noordegraaf
Journal:  J Am Coll Cardiol       Date:  2011-12-06       Impact factor: 24.094

5.  Right ventricular remodeling in idiopathic and scleroderma-associated pulmonary arterial hypertension: two distinct phenotypes.

Authors:  Benjamin W Kelemen; Stephen C Mathai; Ryan J Tedford; Rachel L Damico; Cecilia Corona-Villalobos; Todd M Kolb; Neal F Chaisson; Traci Housten Harris; Stefan L Zimmerman; Ihab R Kamel; David A Kass; Paul M Hassoun
Journal:  Pulm Circ       Date:  2015-06       Impact factor: 3.017

6.  Prognostic value of cardiac magnetic resonance imaging for idiopathic pulmonary arterial hypertension before initiating intravenous prostacyclin therapy.

Authors:  Yoshitake Yamada; Shigeo Okuda; Masaharu Kataoka; Akihiro Tanimoto; Yuichi Tamura; Takayuki Abe; Tomonori Okamura; Keiichi Fukuda; Toru Satoh; Sachio Kuribayashi
Journal:  Circ J       Date:  2012-04-12       Impact factor: 2.993

7.  Interventricular mechanical asynchrony in pulmonary arterial hypertension: left-to-right delay in peak shortening is related to right ventricular overload and left ventricular underfilling.

Authors:  J Tim Marcus; C Tji-Joong Gan; Jaco J M Zwanenburg; Anco Boonstra; Cor P Allaart; Marco J W Götte; Anton Vonk-Noordegraaf
Journal:  J Am Coll Cardiol       Date:  2008-02-19       Impact factor: 24.094

8.  Estimation of right ventricular mass in normal subjects and in patients with primary pulmonary hypertension by nuclear magnetic resonance imaging.

Authors:  J Katz; J Whang; L M Boxt; R J Barst
Journal:  J Am Coll Cardiol       Date:  1993-05       Impact factor: 24.094

9.  Magnetic Resonance Imaging in the Prognostic Evaluation of Patients with Pulmonary Arterial Hypertension.

Authors:  Andrew J Swift; Dave Capener; Chris Johns; Neil Hamilton; Alex Rothman; Charlie Elliot; Robin Condliffe; Athanasios Charalampopoulos; Smitha Rajaram; Allan Lawrie; Michael J Campbell; Jim M Wild; David G Kiely
Journal:  Am J Respir Crit Care Med       Date:  2017-07-15       Impact factor: 21.405

10.  Prognostic value of cardiovascular magnetic resonance imaging measurements corrected for age and sex in idiopathic pulmonary arterial hypertension.

Authors:  Andrew J Swift; Smitha Rajaram; Michael J Campbell; Judith Hurdman; Steve Thomas; Dave Capener; Charlie Elliot; Robin Condliffe; Jim M Wild; David G Kiely
Journal:  Circ Cardiovasc Imaging       Date:  2013-11-25       Impact factor: 7.792
View more
  7 in total

1.  Update in Pulmonary Vascular Diseases and Right Ventricular Dysfunction 2019.

Authors:  Elena A Goncharova; Stephen Y Chan; Corey E Ventetuolo; Norbert Weissmann; Ralph T Schermuly; Christopher J Mullin; Mark T Gladwin
Journal:  Am J Respir Crit Care Med       Date:  2020-07-01       Impact factor: 21.405

Review 2.  Novel Approaches to Imaging the Pulmonary Vasculature and Right Heart.

Authors:  Fawaz Alenezi; Taylor A Covington; Monica Mukherjee; Stephen C Mathai; Paul B Yu; Sudarshan Rajagopal
Journal:  Circ Res       Date:  2022-04-28       Impact factor: 23.213

3.  Allopurinol in Patients with Pulmonary Hypertension Associated with Chronic Lung Disease.

Authors:  Patrick S K Liu-Shiu-Cheong; Brian J Lipworth; Jonathan R Weir-McCall; J Graeme Houston; Allan D Struthers
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-08-25

4.  Against the Odds: Risk Stratification with Cardiac Magnetic Resonance Imaging in Pulmonary Arterial Hypertension.

Authors:  Manuel J Richter; Khodr Tello
Journal:  Am J Respir Crit Care Med       Date:  2020-02-15       Impact factor: 21.405

Review 5.  Cardiac Magnetic Resonance in Pulmonary Hypertension-an Update.

Authors:  Samer Alabed; Pankaj Garg; Christopher S Johns; Faisal Alandejani; Yousef Shahin; Krit Dwivedi; Hamza Zafar; James M Wild; David G Kiely; Andrew J Swift
Journal:  Curr Cardiovasc Imaging Rep       Date:  2020-11-07

6.  Ventricular mass discriminates pulmonary arterial hypertension as redefined at the Sixth World Symposium on Pulmonary Hypertension.

Authors:  Catherine E Simpson; Todd M Kolb; Steven Hsu; Stefan L Zimmerman; Celia P Corona-Villalobos; Stephen C Mathai; Rachel L Damico; Paul M Hassoun
Journal:  Pulm Circ       Date:  2022-01-18       Impact factor: 2.886

7.  Data-driven computational models of ventricular-arterial hemodynamics in pediatric pulmonary arterial hypertension.

Authors:  Christopher Tossas-Betancourt; Nathan Y Li; Sheikh M Shavik; Katherine Afton; Brian Beckman; Wendy Whiteside; Mary K Olive; Heang M Lim; Jimmy C Lu; Christina M Phelps; Robert J Gajarski; Simon Lee; David A Nordsletten; Ronald G Grifka; Adam L Dorfman; Seungik Baek; Lik Chuan Lee; C Alberto Figueroa
Journal:  Front Physiol       Date:  2022-09-07       Impact factor: 4.755
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.